Reranking · Pharmaceuticals

ViDoRe 3 reranking results from MTEB: English queries, the test split, and BM25s first-stage retrieval. Each subject has its own board.

8 entries · nDCG@10 × 100 · Higher is better

Source publication date not supplied. Retrieved 2026-11-05.

Point-estimate ordering. The source supplies no confidence bounds, so small score differences are not evidence of a decisive lead.

Reranking · Pharmaceuticals · nDCG@10 × 100
Score rank	Model / evaluated variant	nDCG@10 × 100
1	nvidia/Nemotron-3.5-Rerank-8B-BF16nvidiaCheckpoint `708e844c3da0`	71.128
2	Qwen/Qwen3-VL-Reranker-8BQwenCheckpoint `407993db318a`	69.828
3	nvidia/llama-nemotron-rerank-vl-1b-v2nvidiaCheckpoint `b8a9987b05b7`	67.44
4	KaLM-Embedding/KaLM-Reranker-V1-Large-R2KaLM-EmbeddingCheckpoint `a862dd8581d4`	66.528
5	Qwen/Qwen3-VL-Reranker-2BQwenCheckpoint `4bd860ac4f15`	66.027
6	KaLM-Embedding/KaLM-Reranker-V1-Small-R2KaLM-EmbeddingCheckpoint `68b74f09ff2a`	65.475
7	KaLM-Embedding/KaLM-Reranker-V1-Nano-R2KaLM-EmbeddingCheckpoint `32b242bb7fd7`	64.317
8	BAAI/bge-reranker-v2-m3BAAICheckpoint `953dc6f6f85a`	63.785

What this ranking can tell you

These are document retrieval rerankers evaluated on a fixed candidate set, not a general language-model ranking.
Coverage is limited to model revisions with this exact published task and English subset. Missing results are not scored.
The source supplies no confidence interval here; the displayed rank orders point estimates and does not establish statistical significance.
No result publication date is supplied. The retrieval date records when the pinned result files were checked.

The original evidence is retained byte for byte. The downloadable board includes the source URLs, revision and SHA-256 hashes.

Source files and licences